Razoxane in treatment of acute myeloid leukaemia.
出版信息
Br Med J. 1978 Oct 21;2(6145):1161. doi: 10.1136/bmj.2.6145.1161.
Abstract
摘要
相似文献
1
Razoxane in treatment of acute myeloid leukaemia.丙亚胺治疗急性髓系白血病
Br Med J. 1978 Oct 21;2(6145):1161. doi: 10.1136/bmj.2.6145.1161.
2
Razoxane in treatment of acute myeloid leukaemia.丙亚胺治疗急性髓细胞白血病
Br Med J. 1978 Oct 14;2(6144):1089-90. doi: 10.1136/bmj.2.6144.1089-d.
3
Razoxane in treatment of acute myeloid leukaemia.丙亚胺治疗急性髓系白血病
Br Med J. 1978 Sep 16;2(6140):801. doi: 10.1136/bmj.2.6140.801.
4
Treatment of blast cell crisis of chronic myeloid leukemia with ICRF-159 (razoxane).用ICRF-159（丙亚胺）治疗慢性髓性白血病的原始细胞危象
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2085-7.
5
Acute myeloid leukaemia after treatment with razoxane.
Br J Dermatol. 1985 Aug;113(2):131-4. doi: 10.1111/j.1365-2133.1985.tb02054.x.
6
Limited activity of ICRF-159 in advanced acute leukemia.ICRF - 159在晚期急性白血病中的活性有限。
Cancer Treat Rep. 1979 Jan;63(1):127-9.
7
8
Acute myelomonocytic leukaemia after razoxane therapy.
Lancet. 1981 Dec 12;2(8259):1343-4. doi: 10.1016/s0140-6736(81)91361-1.
9
Razoxane and leukaemia.丙亚胺与白血病
Lancet. 1984 Aug 4;2(8397):288-9. doi: 10.1016/s0140-6736(84)90330-1.
10
The treatment of acute myeliod leukaemia.急性髓系白血病的治疗
J Clin Pathol. 1974 Jan;27(1):53-4. doi: 10.1136/jcp.27.1.53.
本文引用的文献
1
Mode of action of the cytostatic agent "ICRF 159".细胞生长抑制剂“ICRF 159”的作用方式。
Nature. 1970 May 9;226(5245):524-6. doi: 10.1038/226524a0.
2
Cumulative cytostatic effect of ICRF 159.ICRF 159的累积细胞抑制作用。
Nature. 1974 Feb 15;247(5441):487-90. doi: 10.1038/247487a0.
3
Razoxane in treatment of acute myeloid leukaemia.丙亚胺治疗急性髓系白血病
Br Med J. 1978 Sep 16;2(6140):801. doi: 10.1136/bmj.2.6140.801.
4
Zotero 插件